Alzheimer’s: New blood biomarker may predict risk of cognitive decline
Drug development has tended to focus on targeting amyloid and tau, neglecting the potential role of other brain processes, such as the neuroimmune …
Drug development has tended to focus on targeting amyloid and tau, neglecting the potential role of other brain processes, such as the neuroimmune …
